FDA Approves Qiagen’s Therascreen Urothelial Cancer Companion Diagnostic
Executive Summary
The Therascreen FGFR kit helps identify urothelial tumors with alterations to the fibroblast growth factor receptor 3 gene that indicate the cancer will respond to Janssen’s new drug Balversa.